DSIP/Emideltide was placed on the FDA's Category 2 list of bulk drug substances that may not be compounded due to significant safety risks in September 2023
Potential risks : Unknown long-term effects and quality control issues with compounded peptides pose serious concerns
Like pregnancy, breastfeeding is a high-energy state that can increase the body's need for antioxidant protection
Your desired dose is 500mcg
Beyond the patch itself, we take a holistic approachintegrating lifestyle, nutrition, and supportive therapies to maximize results and promote long-term wellness
A total of 10 highly trained men completed measures of serum EPO concentration, total hemoglobin mass (via carbon monoxide rebreathing), hemoglobin concentration, and reticulocytes before and after 7 days of supplementation with 1800 mg/day of NAC or placebo in a repeated measures, cross-over design with washout